HLCS marketcap is down ~100M past six months,
but newsflow has been good:
ir.helicosbio.com
Helicos BioSciences Enters Molecular Diagnostics Collaboration
with Renowned Research Center to Sequence Cancer-Associated
Genes
Apr 15, 2008
CAMBRIDGE, Mass., Apr 15, 2008 (BUSINESS WIRE) -- Helicos BioSciences (NASDAQ:HLCS), a life science company focused on innovative genetic analysis technologies, today announced a research collaboration with City of Hope focused on cancer molecular diagnostics. City of Hope will use Helicos' proprietary True Single Molecule Sequencing (tSMS)(TM) tec...
Helicos BioSciences Announces Single Molecule DNA Sequence Data Published in Science Magazine
Apr 3, 2008
CAMBRIDGE, Mass., Apr 03, 2008 (BUSINESS WIRE) -- Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the publication of a report in Science Magazine demonstrating the first single molecule sequencing of an organism. The report depicts the use of Helicos' proprietary True S...
Helicos BioSciences Reports 2007 Financial Results
Mar 11, 2008
CAMBRIDGE, Mass., Mar 11, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its financial results for the year ending December 31, 2007 and its business outlook for 2008. "Fiscal 2007 marked Helicos' transition from a R&D focused company to a commercial enterprise with the shipping of the world's first singl...
Helicos BioSciences to Present at Cowen and Company 28th Annual Health Care Conference on Monday, March 17, 2008
Mar 10, 2008
CAMBRIDGE, Mass., Mar 10, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that Mr. Steve Lombardi, president and chief operating officer will provide a company overview at the Cowen and Company 28th Annual Health Care Conference on Monday, March 17, 2008 at The Boston Marriott Copley Place in Boston, Massachus...
Helicos BioSciences Announces Change in Executive Management Team
Mar 7, 2008
CAMBRIDGE, Mass., Mar 07, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that Louise Mawhinney, the company's Senior Vice President and Chief Financial Officer, will be leaving the company to pursue other interests. Ms. Mawhinney has agreed to continue in her position through March 19, 2008 at which time her ...
Helicos BioSciences Announces Shipment of the World's First Single Molecule DNA Sequencer
Mar 5, 2008
CAMBRIDGE, Mass., Mar 05, 2008 (BUSINESS WIRE) -- Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, announced today the first shipment of the Helicos(TM) Genetic Analysis System to Expression Analysis of Durham, North Carolina, the market leader in genomic analysis services. The shipment...
Helicos BioSciences to Report Fourth Quarter and Fiscal Year 2007 Results on March 11, 2008
Mar 4, 2008
CAMBRIDGE, Mass., Mar 04, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will release results for the fourth quarter and fiscal year 2007 on Tuesday, March 11, 2008 at 7:00 a.m. and will host a conference call at 9:00 a.m. EDT. Mr. Stanley Lapidus, Helicos' chairman and chief executive officer and Mr....
Helicos BioSciences Announces First Order for the Helicos(TM) Genetic Analysis Platform
Feb 8, 2008
CAMBRIDGE, Mass., Feb 08, 2008 (BUSINESS WIRE) -- Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced its first order for the Helicos(TM) Genetic Analysis System. The system consists of the HeliScope(TM) Single Molecule Sequencer, the HeliScope(TM) Analysis Engine, and the ...
Helicos BioSciences Validates Performance of True Single Molecule Sequencing
Feb 8, 2008
CAMBRIDGE, Mass., Feb 08, 2008 (BUSINESS WIRE) -- Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced two of its scientists will present performance and application data about the HeliScope(TM) Single Molecule Sequencer. William Efcavitch, PhD, senior vice president of prod...
Helicos BioSciences Endorses the '1000 Genomes Project'
Jan 31, 2008
CAMBRIDGE, Mass., Jan 31, 2008 (BUSINESS WIRE) -- Helicos BioSciences (Nasdaq:HLCS), a life science company focused on innovative genetic analysis technologies, today announced its support for the "1000 Genomes Project." The international consortium's vision of moving the collective knowledge of the human genome forward is an important step toward ...
Helicos BioSciences Appoints Dr. Elisabeth Allison to Board of Directors
Jan 31, 2008
CAMBRIDGE, Mass., Jan 31, 2008 (BUSINESS WIRE) -- Helicos BioSciences (Nasdaq:HLCS), a life science company focused on innovative genetic analysis technologies, announced today that Elisabeth Allison, PhD, has been named to the Helicos Board of Directors. Dr. Allison is a partner at ANZI Partners, a business consulting firm specializing in developm...
Helicos BioSciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Tuesday, February 5, 2008
Jan 29, 2008
CAMBRIDGE, Mass., Jan 29, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Tuesday, February 5, 2008. Mr. Steve Lombardi, President and Chief Operating Officer will present at 8:00 a.m. Eastern time. ...
Helicos BioSciences Announces MicroRNA Collaboration with miRNA Expert
Jan 9, 2008
CAMBRIDGE, Mass., Jan 09, 2008 (BUSINESS WIRE) -- Helicos BioSciences (Nasdaq:HLCS), a life science company focused on innovative genetic analysis technologies, announced today a formal collaboration with Dr. Victor Ambros to apply the quantitative power of True Single Molecule Sequencing (tSMS(TM)) to develop a single assay to characterize known s...
Helicos BioSciences Enters into $20 Million Credit Facility with GE Healthcare Financial Services
Jan 4, 2008
CAMBRIDGE, Mass., Jan 04, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has closed a $20 million senior secured credit facility with GE Healthcare Financial Services. The Company will use the credit facility to support working capital and commercialization efforts. Helicos received $10 million un...
Helicos BioSciences to Present at JPMorgan Healthcare Conference on Thursday, January 10, 2008
Jan 3, 2008
CAMBRIDGE, Mass., Jan 03, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will present at the JPMorgan Healthcare Conference on Thursday, January 10, 2008. Mr. Stanley Lapidus, Chairman and Chief Executive Officer and Mr. Steve Lombardi, President and Chief Operating Officer will present at 10:30 a.m. ...
Helicos BioSciences Joins Personalized Medicine Coalition
Nov 7, 2007
CAMBRIDGE, Mass., Nov 07, 2007 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today it has joined the Personalized Medicine Coalition (PMC), an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine. Helicos BioSciences is a life science company focused on innov...
Ronald Lowy Appointed to Helicos BioSciences' Board of Directors
Nov 5, 2007
CAMBRIDGE, Mass., Nov 05, 2007 (BUSINESS WIRE) -- Helicos BioSciences (Nasdaq:HLCS) announced today that Ronald Lowy, former president and CEO of Fisher Biosciences, has been appointed to the Helicos Board of Directors. Mr. Lowy has extensive experience managing and growing global businesses. As president and CEO of Fisher Biosciences, a divisi...
Helicos BioSciences to Present at the 9th Annual MASS Opportunities Investment Conference on Thursday, November 8, 2007
Nov 1, 2007
CAMBRIDGE, Mass., Nov 01, 2007 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will present at the 9th Annual MASS Opportunities Investment Conference on Thursday, November 8, 2007. Mr. Stanley Lapidus, Chairman and Chief Executive Officer and Mr. Steve Lombardi, President and Chief Operating Officer will p...
Helicos BioSciences Reports Third Quarter 2007 Financial Results
Nov 1, 2007
CAMBRIDGE, Mass., Nov 01, 2007 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its financial results for the third quarter of 2007. For the quarter ended September 30, 2007, the Company reported a net loss attributable to common shareholders of $9,964,000 or $0.48 per share, compared with a net loss attributabl...
Helicos BioSciences to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007
Oct 30, 2007
CAMBRIDGE, Mass., Oct 30, 2007 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007. Mr. Stanley Lapidus, Chairman and Chief Executive Officer and Mr. Steve Lombardi, President and Chief Operating Off... |
